{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:18Z","timestamp":1786119018160,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/jcp.0b013e31818b538d","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T03:12:22Z","timestamp":1226459542000},"page":"711-712","source":"Crossref","is-referenced-by-count":2,"title":["Ziprasidone-Associated Mania in Korean Schizophrenic Patient"],"prefix":"10.1097","volume":"28","author":[{"given":"Young-Min","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Gul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210128","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0893-133X(98)00090-6","article-title":"Ziprasidone 80 mg\/day and 160 mg\/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial.","volume":"20","author":"Daniel","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"R2-25-20210128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4088\/JCP.v65n1116","article-title":"Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.","volume":"65","author":"Rachid","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"R3-25-20210128","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4088\/JCP.v63n1214j","article-title":"A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.","volume":"63","author":"Lu","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"R4-25-20210128","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.CHI.0000070255.24125.03","article-title":"Possible ziprasidone-induced mania.","volume":"42","author":"Larson","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"R5-25-20210128","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4088\/JCP.v64n0317a","article-title":"Mania associated with initiation of ziprasidone.","volume":"64","author":"Nolan","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R6-25-20210128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4088\/JCP.v65n0122a","article-title":"Hypomanic episodes after receiving ziprasidone: an unintended \"on-off-on\" course of treatment.","volume":"65","author":"Brieger","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R7-25-20210128","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1399-5618.2003.02258.x","article-title":"Ziprasidone-associated mania: a case series and review of the mechanism.","volume":"5","author":"Baldassano","year":"2003","journal-title":"Bipolar Disord"},{"issue":"2","key":"R8-25-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.wnf.0000159952.64640.28","article-title":"Ziprasidone-associated mania: a review and report of 2 additional cases.","volume":"28","author":"Keating","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"R9-25-20210128","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.","volume":"25","author":"Meltzer","year":"1989","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"R10-25-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4088\/JCP.v59n0207f","article-title":"Mania induced by risperidone: dose related?","volume":"59","author":"Lane","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"suppl 10","key":"R11-25-20210128","first-page":"15","article-title":"D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.","volume":"60","author":"Remington","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"suppl 37","key":"R12-25-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S0007125000293653","article-title":"Olanzapine: a basic science update.","volume":"176","author":"Bymaster","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"4","key":"R13-25-20210128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pnpbp.2005.11.026","article-title":"Manic\/hypomanic symptoms induced by atypical antipsychotics: a review of the reported cases.","volume":"30","author":"Michalopoulou","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"R14-25-20210128","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism ofatypical antipsychotic-induced cortical dopamine release.","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J Neurochem"},{"issue":"suppl 10","key":"R15-25-20210128","first-page":"5","article-title":"Receptor pharmacology of neuroleptics: relation to clinical effects.","volume":"60","author":"Richelson","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"1-2","key":"R16-25-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.","volume":"124","author":"Scotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"R17-25-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(00)00133-4","article-title":"D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.","volume":"11","author":"Gefvert","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"suppl 13","key":"R18-25-20210128","first-page":"5","article-title":"Quetiapine: preclinical studies, pharmacokinetic, drug interactions, and dosing.","volume":"63","author":"Nemeroff","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R19-25-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: a new hypothesis.","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R20-25-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2006-951609","article-title":"A case of aripiprazole-induced mania.","volume":"40","author":"Traber","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"R21-25-20210128","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R22-25-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/026988110401800308","article-title":"Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.","volume":"18","author":"Hirose","year":"2004","journal-title":"J Psychopharmacol"},{"key":"R23-25-20210128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1192\/bjp.183.2.172","article-title":"Amisulpride-induced mania in a patient with schizophrenia.","volume":"183","author":"Murphy","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"3","key":"R24-25-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"R25-25-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.","volume":"25","author":"Potkin","year":"2005","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e31818b538d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:13:12Z","timestamp":1786036392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200812000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31818b538d","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}